5-METHYL-2-(2-IODOBENZOYL)-3(2H)-ISOXAZOLONE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	FOGKRRWUIDTODH-UHFFFAOYSA-N
Smiles	CC1=CC(=O)N(O1)C(=O)c2ccccc2I
InChI	InChI=1S/C11H8INO3/c1-7-6-10(14)13(16-7)11(15)8-4-2-3-5-9(8)12/h2-6H,1H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C11H8INO3
Molecular Weight	329.09
AlogP	1.8
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	1.0
Polar Surface Area	46.61
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	16.0

Assay Description	Organism	Bioactivity
Fungicidal activity against Alternaria alternata APS-38 assessed as mycelial growth inhibition at 25 mg/L after 3 days	Alternaria alternata	33.0 %
Fungicidal activity against Gaeumannomyces graminis MAFF305168 assessed as mycelial growth inhibition at 25 mg/L after 1 day	Gaeumannomyces graminis	25.0 %
Fungicidal activity against Rhizoctonia solani ET0007 assessed as mycelial growth inhibition at 25 mg/L after 1 day	Rhizoctonia solani	57.0 %
Fungicidal activity against Microdochium nivale IFO-7432 assessed as mycelial growth inhibition at 25 mg/L after 3 days	Microdochium nivale	61.0 %
Fungicidal activity against Zymoseptoria tritici S3 assessed as mycelial growth inhibition at 25 mg/L after 14 days	Zymoseptoria tritici	47.0 %
Fungicidal activity against Rhynchosporium secalis IFO-5290 assessed as mycelial growth inhibition at 25 mg/L after 14 days	Rhynchosporium secalis	100.0 %
Fungicidal activity against Cercospora beticola Be-2-6 assessed as mycelial growth inhibition at 25 mg/L after 7 days	Cercospora beticola	88.0 %
Fungicidal activity against Fusarium graminearum H3 assessed as mycelial growth inhibition at 25 mg/L after 3 days	Fusarium graminearum	36.0 %
Fungicidal activity against Pyrenophora graminea IFO-7507 assessed as mycelial growth inhibition at 25 mg/L after 3 days	Pyrenophora graminea	92.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2270274
PubChem	76326848

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).